We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEO icon
701
American Eagle Outfitters
AEO
$2.85B
$447K 0.01%
+18,000
New +$456K
WRI
702
DELISTED
Weingarten Realty Investors
WRI
$446K 0.01%
15,000
ICUI icon
703
ICU Medical
ICUI
$3.93B
$424K 0.01%
1,500
ELGX
704
DELISTED
Endologix Inc
ELGX
$420K 0.01%
22,000
JACK icon
705
Jack in the Box
JACK
$278M
$419K 0.01%
5,000
CHDN icon
706
Churchill Downs
CHDN
$6.03B
$417K 0.01%
9,000
GIB icon
707
CGI
GIB
$13.9B
$415K 0.01%
6,434
-179
-3% -$11.6K
ONCT
708
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$410K 0.01%
+1,864
New +$4.47M
MCY icon
709
Mercury Insurance
MCY
$5.94B
$401K 0.01%
8,000
PAGP icon
710
Plains GP Holdings
PAGP
$5.23B
$401K 0.01%
16,362
-13,638
-45% -$338K
KGC icon
711
Kinross Gold
KGC
$28.5B
$399K 0.01%
146,452
-566,288
-79% -$1.83M
ATHM icon
712
Autohome
ATHM
$2.43B
$387K 0.01%
5,000
MNDT
713
DELISTED
Mandiant, Inc. Common Stock
MNDT
$382K 0.01%
22,500
WELL icon
714
Welltower
WELL
$178B
$372K ﹤0.01%
5,788
-32,324
-85% -$2.09M
PNQI icon
715
Invesco NASDAQ Internet ETF
PNQI
$501M
$370K ﹤0.01%
13,750
AUY
716
DELISTED
Yamana Gold, Inc.
AUY
$366K ﹤0.01%
146,782
UTHR icon
717
United Therapeutics
UTHR
$26.3B
$358K ﹤0.01%
+2,800
New +$346K
XBI icon
718
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$355K ﹤0.01%
3,705
+775
+26% +$75.1K
ON icon
719
ON Semiconductor
ON
$33.8B
$350K ﹤0.01%
+19,000
New +$406K
QCLS
720
Q/C Technologies Inc
QCLS
$25.4M
$348K ﹤0.01%
+1
New +$338K
EXR icon
721
Extra Space Storage
EXR
$31.2B
$338K ﹤0.01%
+3,900
New +$362K
CVE icon
722
Cenovus Energy
CVE
$54.6B
$331K ﹤0.01%
33,012
-4,630
-12% -$45.2K
SJR
723
DELISTED
Shaw Communications Inc.
SJR
$321K ﹤0.01%
16,506
-115,233
-87% -$2.33M
ARAY icon
724
Accuray
ARAY
$28.4M
$315K ﹤0.01%
70,000
PNW icon
725
Pinnacle West Capital
PNW
$12.9B
$312K ﹤0.01%
3,946

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.